WHO’s Technical Advisory Group on Therapeutics Prioritization (TAG-TP) issued a statement on the use of immunomodulators and host-directed therapies for treating Bundibugyo virus disease, a species of filovirus. The guidance reflects expert review of available evidence for these treatment approaches.
TAG-TP statement on immunomodulators and host-directed therapies for Bundibugyo virus disease
calendar_today
June 26, 2026
domain
who